PHOBRIGA (Brigatinib) 90mg*30's | Generic ALK Inhibitor Laos | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

مشاركة
Product description

Generic Information: PHOBRIGA (Laos)

PHOBRIGA is a Lao-manufactured generic of brigatinib, produced by Pharmaceutical Factory No.2, Vientiane, Laos (commonly known as the Lao "Second Factory"). It is supplied as 90 mg tablets in a 30-tablet pack, matching the lead-in and standard maintenance starting dose of the brigatinib regimen. As a second-generation ALK inhibitor generic, PHOBRIGA provides the same active ingredient as the originator at a lower cost.

What Is PHOBRIGA Used For?

PHOBRIGA is used to treat anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer, including in patients who have progressed on or cannot tolerate crizotinib. It is an oral, once-daily monotherapy that keeps treatment simple and home-based, and it is prescribed only after a genetic test confirms the ALK rearrangement.

How Does PHOBRIGA (Brigatinib) Work?

The active ingredient brigatinib is a next-generation ALK inhibitor that also targets ROS1, IGF-1R, and FLT-3. It shuts down ALK-driven growth signaling and penetrates the brain, which helps control brain metastases. The generic PHOBRIGA reproduces the same mechanism and active ingredient as the originator at a more accessible price.

Indications

PHOBRIGA is indicated for adults with ALK-positive, locally advanced or metastatic NSCLC. A confirmed ALK rearrangement is required before prescribing. The medicine is not suitable for ALK-negative tumors and is not indicated for small-cell lung cancer.

Dosage

The standard schedule is 90 mg once daily for the first 7 days, then 180 mg once daily if tolerated. The 90 mg tablets in this listing support the lead-in phase and the 90 mg maintenance dose. Take the tablet with or without food at the same time each day and swallow it whole. Do not double up on a missed or vomited dose.

Side Effects

Common side effects include diarrhea, rash, cough, high blood pressure, fatigue, nausea, muscle pain, and headache. Blood pressure should be checked regularly, and diarrhea is usually manageable with supportive care. Interstitial lung disease is rare but serious and requires permanent discontinuation if confirmed.

Storage

Store PHOBRIGA below 30°C in a dry place, inside the original packaging, and away from children. There is no cold-chain requirement.

Why Choose the GLT?

For patients who pay for treatment themselves, a Lao generic such as PHOBRIGA is a far more economical option than the originator brand, whose Western list price can be several times higher. GLT sources from established manufacturers and provides the documentation needed for international delivery, so patients can keep up affordable, uninterrupted therapy.

How to Order

To order PHOBRIGA through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Tell us the strength, quantity, and your country, and our team will confirm stock, sourcing origin, and delivery details. We serve hospitals, pharmacies, and individual patients alike.

FAQ

Is PHOBRIGA a generic of brigatinib? Yes. PHOBRIGA is a Lao-manufactured generic of brigatinib, produced by Pharmaceutical Factory No.2, Vientiane, Laos.

What strength does PHOBRIGA come in? This listing is the 90 mg strength in a 30-tablet box, which matches the lead-in dose and the standard 90 mg maintenance dose of the brigatinib schedule.

Where can I buy generic brigatinib? Generic brigatinib can be sourced through international suppliers such as GLT. Always verify the supplier and request proper documentation before purchasing.

Related Oncology Products

إلترومبوباغ (Promacta) أقراص 25/50 ملغ | ناهض TPO-R أصلي أمريكي | GLT

Promacta الأصلي من Novartis (إلترومبوباغ) 25 ملغ و50 ملغ، 30 قرصًا

تيكسيبا (تيرزيباتيد) 20ملغ/2مل و30ملغ/2مل قلم متعدد الجرعات | دراغ إنترناشيونال | GLT

تيكسيبا — قلم متعدد الجرعات من تيرزيباتيد دراغ إنترناشيونال المحدودة (DIL)، بجرعتين رسميتين (تيكسيبا-5 =...

أولوميانت (باريسيتينيب) أقراص 2ملغ/4ملغ | مثبط JAK1/JAK2 | إيلي ليلي (الولايات المتحدة) | GLT

مثبط انتقائي لـ JAK1/JAK2 من إيلي ليلي لعلاج التهاب المفاصل الروماتويدي والتهاب الجلد التأتبي والثعلبة...

أورفورغليبرون (لوسيورفور) أقراص 0.8–17.2 ملغ | دواء جينيريك لاوسي فموي GLP-1 | GLT

جينيريك أورفورغليبرون من Lucius Pharmaceuticals (لاوس)، نظام معايرة من 6 جرعات لإدارة الوزن

أورفورغليبرون (OriYo) أقراص 0.8–17.2 ملغ | دواء جينيريك بنغلاديشي فموي GLP-1 | GLT

جينيريك أورفورغليبرون من National Drug Co. (بنغلاديش)، نظام معايرة من 6 جرعات لإدارة الوزن

زيباوند (تيرزيباتيد) 2.5–15ملغ/0.5مل قلم أحادي الجرعة | إيلي ليلي (الولايات المتحدة) | GLT

زيباوند — قلم أحادي الجرعة من تيرزيباتيد إيلي ليلي، بستة جرعات أمريكية (2.5–15ملغ/0.5مل) لإدارة الوزن...

تيرزيما (تيرزيباتيد) 2.5/5/7.5ملغ/0.5مل قلم أحادي الجرعة | إنسبتا (بنغلاديش) | GLT

تيرزيما — قلم أحادي الجرعة من تيرزيباتيد إنسبتا للأدوية، بثلاث جرعات رسمية (2.5/5/7.5ملغ/0.5مل) لمرض السكري...

بارينيب (باريسيتينيب) 2ملغ | مثبط JAK1/JAK2 جنيس | دراغ إنترناشيونال المحدودة | GLT

باريسيتينيب جنيس (مثبط JAK1/JAK2) من دراغ إنترناشيونال المحدودة (بنغلاديش) — بديل ميسور التكلفة عن أولوميانت...